These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32878305)

  • 1. The Development of Hyaluronan/Fucoidan-Based Nanoparticles as Macrophages Targeting an Epigallocatechin-3-Gallate Delivery System.
    Ho CH; Chu PY; Peng SL; Huang SC; Lin YH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Delivery of Natural Compounds with a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model.
    Chu PY; Tsai SC; Ko HY; Wu CC; Lin YH
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23880-23892. PubMed ID: 31192580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.
    Huang HY; Wang MC; Chen ZY; Chiu WY; Chen KH; Lin IC; Yang WV; Wu CC; Tseng CL
    Int J Nanomedicine; 2018; 13():7251-7273. PubMed ID: 30510416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal Macrophage-Specific TNF-α Gene Silencing in LPS-Induced Acute Inflammation Model Using CD44 Targeting Hyaluronic Acid Nanoparticles.
    Kosovrasti VY; Nechev LV; Amiji MM
    Mol Pharm; 2016 Oct; 13(10):3404-3416. PubMed ID: 27552547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan/fucoidan nanoparticles.
    Huang TW; Ho YC; Tsai TN; Tseng CL; Lin C; Mi FL
    Carbohydr Polym; 2020 Aug; 242():116312. PubMed ID: 32564860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
    Zhang J; Nie S; Zu Y; Abbasi M; Cao J; Li C; Wu D; Labib S; Brackee G; Shen CL; Wang S
    J Control Release; 2019 Jun; 303():263-273. PubMed ID: 30999008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage.
    Avadhani KS; Manikkath J; Tiwari M; Chandrasekhar M; Godavarthi A; Vidya SM; Hariharapura RC; Kalthur G; Udupa N; Mutalik S
    Drug Deliv; 2017 Nov; 24(1):61-74. PubMed ID: 28155509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
    Zhang J; Nie S; Martinez-Zaguilan R; Sennoune SR; Wang S
    J Nutr Biochem; 2016 Apr; 30():14-23. PubMed ID: 27012617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
    Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.
    Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X
    Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
    Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
    Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route.
    Jeannot V; Mazzaferro S; Lavaud J; Vanwonterghem L; Henry M; Arboléas M; Vollaire J; Josserand V; Coll JL; Lecommandoux S; Schatz C; Hurbin A
    Nanomedicine; 2016 May; 12(4):921-932. PubMed ID: 26724540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.
    Zhang J; Nie S; Wang S
    J Agric Food Chem; 2013 Sep; 61(38):9200-9. PubMed ID: 24020822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
    Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
    J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-osteoclastogenic effect of epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo.
    Zhu S; Zhu L; Yu J; Wang Y; Peng B
    Int J Nanomedicine; 2019; 14():5017-5032. PubMed ID: 31371944
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages.
    Zhong Y; Chiou YS; Pan MH; Shahidi F
    Food Chem; 2012 Sep; 134(2):742-8. PubMed ID: 23107686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.